Skip to content

A multicenter, randomized, single-blind, positive-parallel control trial for SIS tissue repair materials used in vaginal repair and reconstruction

A multicenter, randomized, single-blind, positive-parallel control trial for SIS tissue repair materials used in vaginal repair and reconstruction

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030107
Enrollment
Unknown
Registered
2020-02-23
Start date
2019-06-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal reconstruction such as Mayer-Rokitansky-Kuster-Hauser ?Vaginal atresia? Vulvovaginal trauma and Benign tumor of vulva

Interventions

Experimental group:SIS tissue repair materials
control group:Cook-Soft tissue patch

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Women aged 18 to 50 years; 2) Patients who intend to undergo vaginal repair or reconstruction, including Mayer-Rokitansky-Kuster-HauserVaginal atresia, Vulvovaginal trauma and Benign tumor of vulva; 3) Patients who can communicate well with researchers; 4) Informed consent, voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Women during pregnancy; 2) Patients with malignant tumors; 3) Class III and above cardiac function; 4) ECG examination revealed the following abnormalities: premature contraction, atrial flutter, atrial fibrillation, ventricular tachycardia, and hemodynamically unstable malignant arrhythmia; 5) Blood IgG or blood IgA or blood IgM is more than 1.5 times ULN; ALT or AST or BUN or PT is more than 1.5 times ULN; 6) Patients with unconsciousness, mental illness or severe mental illness; 7) Patients with contraindications to the use of pig-derived products; 8) Patients who have participated in other clinical trials within 30 days before the date of signing or signing the informed consent form; 9) The investigator believes that other patients are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Vaginal length >=8cm;The width of the cavity can easily accommodate 2 fingers;

Secondary

MeasureTime frame
Colposcopy confirms mucosalization of tissue at the repair site;Product performance evaluation;

Countries

China

Contacts

Public ContactJianhua Liu

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

drliu.2006@aliyun.com+86 13701911503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026